Renovacor, Inc., (RCOR): Price and Financial Metrics
RCOR Price/Volume Stats
| Current price | $3.20 | 52-week high | $9.74 |
| Prev. close | $3.05 | 52-week low | $1.34 |
| Day low | $3.00 | Volume | 14,300 |
| Day high | $3.20 | Avg. volume | 30,033 |
| 50-day MA | $2.74 | Dividend yield | N/A |
| 200-day MA | $3.00 | Market Cap | 55.26M |
RCOR Stock Price Chart Interactive Chart >
Renovacor, Inc., (RCOR) Company Bio
Renovacor, Inc., an early-stage biotechnology company, engages in developing a pipeline of adeno-associated virus (AAV) based gene therapies for Bcl2-associated athanogene 3 (BAG3) associated diseases. Its lead program is recombinant AAV-based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the BAG3 gene; and REN-001, an AAV9-based gene therapy to treat BAG3-associated DCM. The company was incorporated in 2013 and is based in Greenwich, Connecticut.
RCOR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -63.34% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -24.51% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...